135 related articles for article (PubMed ID: 30929573)
1. A Novel Diagnostic Method for Thyroid Follicular Tumors Based on Immunofluorescence Analysis of p53-Binding Protein 1 Expression: Detection of Genomic Instability.
Otsubo R; Matsuda K; Mussazhanova Z; Sato A; Matsumoto M; Yano H; Oikawa M; Kondo H; Ito M; Miyauchi A; Hirokawa M; Nagayasu T; Nakashima M
Thyroid; 2019 May; 29(5):657-665. PubMed ID: 30929573
[No Abstract] [Full Text] [Related]
2. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
Mussazhanova Z; Akazawa Y; Matsuda K; Shichijo K; Miura S; Otsubo R; Oikawa M; Yoshiura K; Mitsutake N; Rogounovitch T; Saenko V; Kozykenova Z; Zhetpisbaev B; Shabdarbaeva D; Sayakenov N; Amantayev B; Kondo H; Ito M; Nakashima M
Endocr J; 2016 May; 63(5):457-67. PubMed ID: 26935218
[TBL] [Abstract][Full Text] [Related]
3. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis.
Nakashima M; Suzuki K; Meirmanov S; Naruke Y; Matsuu-Matsuyama M; Shichijo K; Saenko V; Kondo H; Hayashi T; Ito M; Yamashita S; Sekine I
Int J Cancer; 2008 Mar; 122(5):1082-8. PubMed ID: 17985346
[TBL] [Abstract][Full Text] [Related]
4. 53BP1 expression as a biomarker to differentiate thyroid follicular tumors.
Sato A; Matsuda K; Motoyama T; Mussazhanova Z; Otsubo R; Kondo H; Akazawa Y; Higuchi M; Suzuki A; Hirokawa M; Miyauchi A; Nagayasu T; Nakashima M
Endocr Connect; 2021 Mar; 10(3):309-315. PubMed ID: 33617469
[TBL] [Abstract][Full Text] [Related]
5. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability.
Naruke Y; Nakashima M; Suzuki K; Matsuu-Matsuyama M; Shichijo K; Kondo H; Sekine I
Cancer Sci; 2008 May; 99(5):946-51. PubMed ID: 18380789
[TBL] [Abstract][Full Text] [Related]
6. Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis.
Matsuda K; Miura S; Kurashige T; Suzuki K; Kondo H; Ihara M; Nakajima H; Masuzaki H; Nakashima M
Histopathology; 2011 Sep; 59(3):441-51. PubMed ID: 22034884
[TBL] [Abstract][Full Text] [Related]
7. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
9. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
[TBL] [Abstract][Full Text] [Related]
10. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Cho Mar K; Eimoto T; Tateyama H; Arai Y; Fujiyoshi Y; Hamaguchi M
Histopathology; 2006 Feb; 48(3):286-94. PubMed ID: 16430475
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorescence analysis of DNA damage response protein p53-binding protein 1 in a case of uterine dedifferentiated leiomyosarcoma arising from leiomyoma.
Matsuda K; Akazawa Y; Yamaguchi Y; Mussazhanova Z; Kurohama H; Ueki N; Kohno M; Fukushima A; Kajimura I; Hiraki H; Matsuwaki T; Kawashita S; Kinoshita A; Nakashima M
Pathol Res Pract; 2019 Nov; 215(11):152640. PubMed ID: 31570279
[TBL] [Abstract][Full Text] [Related]
13. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status.
Mussazhanova Z; Matsuda K; Naruke Y; Mitsutake N; Stanojevic B; Rougounovitch T; Saenko V; Suzuki K; Nishihara E; Hirokawa M; Ito M; Nakashima M
Histopathology; 2013 Nov; 63(5):726-34. PubMed ID: 24004175
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
[TBL] [Abstract][Full Text] [Related]
15. Detection of Endogenous DNA Double-strand Breaks in Oral Squamous Epithelial Lesions by P53-binding Protein 1.
Imaizumi T; Matsuda K; Tanaka K; Kondo H; Ueki N; Kurohama H; Otsubo C; Matsuoka Y; Akazawa Y; Miura S; Nakashima M
Anticancer Res; 2021 Oct; 41(10):4771-4779. PubMed ID: 34593426
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
[TBL] [Abstract][Full Text] [Related]
17. DNA copy number variations characterize benign and malignant thyroid tumors.
Liu Y; Cope L; Sun W; Wang Y; Prasad N; Sangenario L; Talbot K; Somervell H; Westra W; Bishop J; Califano J; Zeiger M; Umbricht C
J Clin Endocrinol Metab; 2013 Mar; 98(3):E558-66. PubMed ID: 23345095
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathological Characteristics of Thyroid Follicular-Patterned Tumors Showing Nodule-in-Nodule Appearance with Poorly Differentiated Component.
Ueda M; Matsuda K; Kurohama H; Mussazhanova Z; Sailaubekova Y; Kondo H; Shimizu T; Takada N; Matsuoka Y; Otsubo C; Sato S; Yamashita H; Kawakami A; Nakashima M
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892838
[TBL] [Abstract][Full Text] [Related]
20. Significance of abnormal 53BP1 expression as a novel molecular pathologic parameter of follicular-shaped B-cell lymphoid lesions in human digestive tract.
Luong TMH; Matsuda K; Niino D; Kurohama H; Ito M; Nakashima M
Sci Rep; 2021 Feb; 11(1):3074. PubMed ID: 33542453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
